about
HER2-positive male breast cancer: an update.High-throughput microRNA profiling of pediatric high-grade gliomas.Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors.Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancer.PCAF ubiquitin ligase activity inhibits Hedgehog/Gli1 signaling in p53-dependent response to genotoxic stress.Vemurafenib and panitumumab combination tailored therapy in BRAF-mutated metastatic colorectal cancer: a case report.microRNA-17-92 cluster is a direct Nanog target and controls neural stem cell through Trp53inp1.Novel and recurrent BRCA2 mutations in Italian breast/ovarian cancer families widen the ovarian cancer cluster region boundaries to exons 13 and 14.PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms.Association of SULT1A1 Arg²¹³His polymorphism with male breast cancer risk: results from a multicenter study in Italy.Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy: The Galectin-3 Signature in NSCLCsPrevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer familiesDoes the search for large genomic rearrangements impact BRCAPRO carrier prediction?Improving the accuracy of BRCA1/2 mutation prediction: validation of the novel country-customized IC softwareClinical classification of BRCA1 DNA missense variants: H1686Q is a novel pathogenic mutation occurring in the ontogenetically invariant THV motif of the N-terminal BRCT domainBRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction modelsKras/ADAM17-Dependent Jag1-ICD Reverse Signaling Sustains Colorectal Cancer Progression and ChemoresistanceERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of βTrCPSMO-M2 mutation does not support cell-autonomous Hedgehog activity in cerebellar granule cell precursors
P50
Q37355586-D2895347-9545-49EA-839A-6CF4B55042CBQ37492187-CA22FC25-3412-4AFF-8A20-26283F116A75Q37680170-41E52FBD-F271-4371-9C11-7B0C8E4E9304Q39018250-3779A5FC-C333-469E-B0AB-42476C4AA46BQ39098638-80074F41-B38A-4AE7-A5C2-74C7C15482E5Q41852171-6FA0BA3A-2FA6-4C2D-B6F4-E8049DF56A78Q42921751-5B6590A9-B7EE-48B0-B05E-723866774289Q44556540-B5E19A31-C085-4BF8-91BE-9B47EE8AA044Q46022493-94DCB477-531B-4886-B39C-AD4370A78059Q51102259-F085DBA9-DFCB-45F8-82AF-197892F73688Q64098932-50A6D73E-917D-4100-AB20-E4B08EA62B7DQ79859246-BA33730B-9723-4C45-8B84-EFF919C0A3CEQ80495899-87BE317D-34E5-454D-AA29-2F784F100AD3Q81481436-FCAE04A7-DB16-4CF4-921F-4416AB3B37FEQ81895458-45FF846A-FD06-47C3-91DF-A1533485B7C9Q83946484-6DAC678F-6C5D-4FB8-9E86-2DC2D66B43A1Q90044005-62AA7F6F-F9D8-4455-AB02-849866D03194Q92153532-6AB2D20B-8F25-4112-9E5C-5FC43FFA8CE2Q92229034-647C7E6F-41BA-4FE7-9A10-CF959BAE4EBB
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Carlo Capalbo
@ast
Carlo Capalbo
@en
Carlo Capalbo
@es
Carlo Capalbo
@nl
type
label
Carlo Capalbo
@ast
Carlo Capalbo
@en
Carlo Capalbo
@es
Carlo Capalbo
@nl
prefLabel
Carlo Capalbo
@ast
Carlo Capalbo
@en
Carlo Capalbo
@es
Carlo Capalbo
@nl
P106
P1153
6506667309
P31
P496
0000-0001-8445-6782